> ## Documentation Index
> Fetch the complete documentation index at: https://resources.pipelinebio.com/llms.txt
> Use this file to discover all available pages before exploring further.

# Insights: Articles and Ecosystem Reports

> Pipeline Bio articles and ecosystem reports on scientific sourcing, the Capability Taxonomy, the R&D Tax Incentive, quality frameworks, and the shape of the life science Provider landscape.

Perspectives and analysis on scientific sourcing, R\&D procurement, and the infrastructure connecting life science teams with the capability their work demands.

## Ecosystem reports

Pipeline Bio Ecosystem Analytics is a structured analysis of life science Provider landscapes, built on the Pipeline Bio Database. Each report maps where capability exists, how it is distributed, and what that means for teams sourcing it and Providers positioning against it.

<Card title="The Shape, Spread, and Structure of Australia's Fee-for-Service Life-Sciences Capability" icon="chart-network" href="/resources/reports/australia-2026-july">
  **Australia · July 2026 · James Cooney and Nenad Sejic**

  258 Providers, 5,944 catalogued capabilities, analysed across the Capability Taxonomy by category, geography, and Provider structure.
</Card>

| Measure                                  | Finding                                                       |
| ---------------------------------------- | ------------------------------------------------------------- |
| Providers in the Database                | 258                                                           |
| Fee-for-service capabilities catalogued  | 5,944                                                         |
| Share held by the two largest categories | 47.6% of core capability                                      |
| Geographic concentration                 | Victoria and New South Wales hold 68% of state-level listings |
| Thinnest core category                   | Medical Device Capabilities, 34 active Providers              |
| Provider breadth                         | 55% work in only one or two core categories                   |

## Using the Platform

<CardGroup cols={2}>
  <Card title="Finding R&D Providers with Pipeline Bio" href="/resources/articles/find-scientific-services">
    The Directory of Providers, the Catalogue of Capabilities, the AI Search Agent, shortlisting, and moving from enquiry to RFP.

    **6 minute read · 2 June 2026**
  </Card>

  <Card title="What Managing a Storefront on Pipeline Bio Is Like" href="/resources/articles/storefront-management-for-providers">
    Be discoverable without adding overheads: claiming a Storefront, Capability Listings, Profile Strength, and responding to enquiries.

    **4 minute read · 15 June 2026**
  </Card>

  <Card title="The Capability Taxonomy" href="/resources/articles/capability-taxonomy">
    How a four-level hierarchy brings structure to Australia's R\&D ecosystem, and how to use it to find and compare capabilities.

    **6 minute read · 22 May 2026**
  </Card>
</CardGroup>

## The sector and its economics

<CardGroup cols={2}>
  <Card title="Why Australia Needs a Centralised Platform for Scientific Services" href="/resources/articles/why-australia-needs-a-scientific-services-platform">
    A highly capable but poorly connected ecosystem, what fragmentation costs both sides, and what centralised infrastructure changes.

    **8 minute read · 6 May 2026**
  </Card>

  <Card title="The Hidden Costs of Biotech R&D" href="/resources/articles/hidden-costs-of-biotech-r-and-d">
    Where the money actually goes, why costs escalate, where capital leaks, and five questions investors can ask.

    **6 minute read · 6 May 2026**
  </Card>
</CardGroup>

## Funding and compliance

<CardGroup cols={2}>
  <Card title="Australia's R&D Tax Incentive for Biotech" href="/resources/articles/australian-rdti-biotech">
    Refunds, reforms, and outsourced research: how the RDTI works, how overseas work is treated, and what changes from 1 July 2028.

    **8 minute read · 15 May 2026**
  </Card>

  <Card title="Understanding ISO and GLP Compliance in Research Services" href="/resources/articles/iso-vs-glp-compliance-biotechnology-research">
    What GLP covers, which ISO standards apply to research and analytical laboratories, and how the two frameworks complement each other.

    **3 minute read · 11 November 2025**
  </Card>
</CardGroup>

## About the report series

Reports capture a point-in-time snapshot of Provider listings and their Classifications within the Capability Taxonomy. Data is collected from publicly available information — Provider websites, brochures, and interviews — or entered by Providers themselves.

<Note>
  Inclusion in the Database indicates that a capability has been identified and classified from available information. It does not assess the quality, suitability, regulatory status, capacity, or performance of that capability, nor does it constitute an endorsement of any Provider by Pipeline Bio.
</Note>